509 related articles for article (PubMed ID: 36287004)
1. Berberine Depresses Inflammation and Adjusts Smooth Muscle to Ameliorate Ulcerative Colitis of Cats by Regulating Gut Microbiota.
Li X; Xu S; Zhang Y; Li K; Gao XJ; Guo MY
Microbiol Spectr; 2022 Dec; 10(6):e0320722. PubMed ID: 36287004
[TBL] [Abstract][Full Text] [Related]
2. Berberine ameliorates DSS-induced intestinal mucosal barrier dysfunction through microbiota-dependence and Wnt/β-catenin pathway.
Dong Y; Fan H; Zhang Z; Jiang F; Li M; Zhou H; Guo W; Zhang Z; Kang Z; Gui Y; Shou Z; Li J; Zhu R; Fu Y; Sarapultsev A; Wang H; Luo S; Zhang G; Hu D
Int J Biol Sci; 2022; 18(4):1381-1397. PubMed ID: 35280677
[TBL] [Abstract][Full Text] [Related]
3. Combination of Coptis chinensis polysaccharides and berberine ameliorates ulcerative colitis by regulating gut microbiota and activating AhR/IL-22 pathway.
Wang X; Liang F; Dai Z; Feng X; Qiu F
J Ethnopharmacol; 2024 Jan; 318(Pt B):117050. PubMed ID: 37595814
[TBL] [Abstract][Full Text] [Related]
4. Berberine alleviates inflammation and suppresses PLA2-COX-2-PGE2-EP2 pathway through targeting gut microbiota in DSS-induced ulcerative colitis.
Yu H; Zhang S; Li R; Ma C; Zhang Q; Xia F; Zhou B; Xie Z; Liao Z
Biochem Biophys Res Commun; 2024 Feb; 695():149411. PubMed ID: 38154262
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
6. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
7.
Wang J; Su L; Zhang L; Zeng J; Chen Q; Deng R; Wang Z; Kuang W; Jin X; Gui S; Xu Y; Lu X
J Zhejiang Univ Sci B; 2022 Jun; 23(6):481-501. PubMed ID: 35686527
[TBL] [Abstract][Full Text] [Related]
8. Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner.
Li Q; Cui Y; Xu B; Wang Y; Lv F; Li Z; Li H; Chen X; Peng X; Chen Y; Wu E; Qu D; Jian Y; Si H
Pharmacol Res; 2021 Aug; 170():105694. PubMed ID: 34087350
[TBL] [Abstract][Full Text] [Related]
9. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
Front Immunol; 2021; 12():679897. PubMed ID: 34367139
[TBL] [Abstract][Full Text] [Related]
10. Berberine improves DSS-induced colitis in mice by modulating the fecal-bacteria-related bile acid metabolism.
Sun X; Zhang Y; Cheng G; Zhu T; Zhang Z; Xiong L; Hu H; Liu H
Biomed Pharmacother; 2023 Nov; 167():115430. PubMed ID: 37683590
[TBL] [Abstract][Full Text] [Related]
11. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites.
Jing W; Dong S; Luo X; Liu J; Wei B; Du W; Yang L; Luo H; Wang Y; Wang S; Lu H
Pharmacol Res; 2021 Feb; 164():105358. PubMed ID: 33285228
[TBL] [Abstract][Full Text] [Related]
12. Effect and Mechanism of Pharmaceutical Excipients on Berberine to Alleviate Ulcerative Colitis via Regulating Gut Microbiota.
Wu C; Zheng T; Chen H; Zou P; Zhang M; Wang J; Li N; Zhang Y; Li Y; Dong Z
Molecules; 2022 Sep; 27(18):. PubMed ID: 36144733
[TBL] [Abstract][Full Text] [Related]
13. Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota.
Feng W; Zhang Y; Zhang Y; Dong Y; Wu J; Chen Q; Liu M; Wang D; Wu Y; Wang T
Eur J Pharmacol; 2024 Jan; 963():176164. PubMed ID: 37918500
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of berberine hydrochloride and dehydrocostus lactone in the treatment of ulcerative colitis: Take gut microbiota as the target.
Xu C; Zhao L; Zhou W; Li Y; Hu H; Wang Z
Int Immunopharmacol; 2023 Nov; 124(Pt B):111009. PubMed ID: 37820424
[TBL] [Abstract][Full Text] [Related]
15. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades.
Wang K; Guo J; Chang X; Gui S
J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325
[TBL] [Abstract][Full Text] [Related]
16. Quinoa bran soluble dietary fiber ameliorates dextran sodium sulfate induced ulcerative colitis in BALB/c mice by maintaining intestinal barrier function and modulating gut microbiota.
Liu J; Wang Z; Mai P; Hao Y; Wang Z; Wang J
Int J Biol Macromol; 2022 Sep; 216():75-85. PubMed ID: 35792311
[TBL] [Abstract][Full Text] [Related]
17. Xianglian pill modulates gut microbial production of succinate and induces regulatory T cells to alleviate ulcerative colitis in rats.
Liu CS; Hu YX; Luo ZY; Qiu CW; Deng XH; Chen FL
J Ethnopharmacol; 2023 Mar; 303():116007. PubMed ID: 36473618
[TBL] [Abstract][Full Text] [Related]
18. Gegen Qinlian decoction activates AhR/IL-22 to repair intestinal barrier by modulating gut microbiota-related tryptophan metabolism in ulcerative colitis mice.
Wang X; Huang S; Zhang M; Su Y; Pan Z; Liang J; Xie X; Wang Q; Chen J; Zhou L; Luo X
J Ethnopharmacol; 2023 Feb; 302(Pt B):115919. PubMed ID: 36356716
[TBL] [Abstract][Full Text] [Related]
19. Sustained ameliorative effect of Lactobacillus acidophilus LA85 on dextran sulfate sodium-induced colitis in mice.
Han M; Liao W; Dong Y; Fei T; Gai Z
J Food Sci; 2023 Sep; 88(9):3893-3904. PubMed ID: 37548631
[TBL] [Abstract][Full Text] [Related]
20. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
